Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States
Dr. Rogers in an interventional cardiologist and scientific lead for the MedStar Heart & Vascular Institute Structural Heart Disease program. He has a special interest in all aspects of transcatheter treatment of structural heart disease and is an expert in the field of transcatheter electrosurgery including LAMPOON, BASILICA, SESAME and transcaval.
Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)
Sunday, March 9, 2025
8:00 AM – 9:45 AM ET
Panel Discussion | What Do We Need to Know on Lifetime Management?
Sunday, March 9, 2025
9:28 AM – 9:45 AM ET
TAV-IN-TAV LIVE CT ANALYSIS USING REDO TAV APP
Sunday, March 9, 2025
11:30 AM – 12:30 PM ET
TAV-in-TAV Live CT Analysis Using Redo TAV App | Case Presentation
Sunday, March 9, 2025
12:00 PM – 12:15 PM ET
Sunday, March 9, 2025
12:15 PM – 12:30 PM ET
Live Case from MedStar Washington Hospital Center | Washington, DC
Monday, March 10, 2025
9:00 AM – 9:45 AM ET
Live Case from Stanford Health Care Tri-Valley | Stanford, CA
Monday, March 10, 2025
11:00 AM – 11:45 AM ET
Monday, March 10, 2025
11:50 AM – 12:00 PM ET
Panel Discussion | Prevalence Impact and Management of HALT and Valve Thrombosis
Monday, March 10, 2025
2:12 PM – 2:30 PM ET
Monday, March 10, 2025
2:00 PM – 2:02 PM ET
EVIDENCE BASE AND REGULATORY PATHWAYS
Monday, March 10, 2025
3:48 PM – 4:44 PM ET
Monday, March 10, 2025
4:16 PM – 4:36 PM ET
Panel Discussion | TAVR Lifetime Management
Monday, March 10, 2025
2:32 PM – 3:00 PM ET
EARLY FEASIBILITY STUDIES | STRUCTURAL
Monday, March 10, 2025
2:00 PM – 3:30 PM ET
DEVICES TO MANAGE AORTIC VALVE DISEASE
Tuesday, March 11, 2025
8:00 AM – 10:00 AM ET
Panel Discussion | Second- and Third-Generation Aortic Valve Systems Not Yet Approved in the US
Tuesday, March 11, 2025
9:44 AM – 10:00 AM ET
Tuesday, March 11, 2025
12:12 PM – 12:30 PM ET
Tuesday, March 11, 2025
12:30 PM – 12:35 PM ET